Help us shape the future of the Legislature website!

We are redesigning our website and want your feedback. We are looking for volunteers to participate in research, and some opportunities may be paid.    Sign up to participate here!
Bill Information > HB 2710
Search for another bill or initiative:
HB 2710 - 2019-20
Modifying the uses, disclosure, and requirement dates of prescription drug price transparency data.
Sponsors: Robinson, Tarleton, Cody, Tharinger, Ormsby
Bill History

2020 REGULAR SESSION

Jan 20
First reading, referred to Health Care & Wellness. (View Original Bill)
Jan 29
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)
Feb 4
Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)
HCW - Majority; do pass. (Majority Report)
Feb 6
Referred to Rules 2 Review.
Feb 16
Rules Committee relieved of further consideration. Placed on second reading.
Feb 17
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 56; nays, 42; absent, 0; excused, 0. (View Roll Calls)

IN THE SENATE

Feb 19
First reading, referred to Health & Long Term Care.
Feb 28
Public hearing and executive session scheduled, but no action was taken in the Senate Committee on Health & Long Term Care at 8:00 AM. (Committee Materials)
Mar 12
By resolution, returned to House Rules Committee for third reading.
Available Documents
For a complete list of documents, go to Online Reports Text of a Legislative Document.
Fiscal Note
Amendments
Available Videos